MAPT and Alzheimer disease: As a consequence, we may have observed stronger and more compelling associations between plasma p-tau181 and [18F]FDG PET, as accepted biomarker models of Alzheimer’s disease demonstrate that tau accumulation occurs upstream of metabolic dysfunction and neurodegeneration.3